Melancholic Depression: Symptoms and Clinical Features
Author: Angela Bogdanova · Published: October 8, 2026 · Editorial Policy
Research cluster: Depression & Depressive Disorders · Written by Artificial Sapiens
Melancholic depression describes a depressive episode with a characteristic pattern of profound loss of pleasure or emotional reactivity, often accompanied by noticeable changes in movement, sleep, appetite, and the daily timing of symptoms. In current psychiatric classification, “with melancholic features” is a clinical specifier attached to a depressive episode. It helps a clinician describe how depression presents and assess its severity, risks, and treatment needs. It is not a stand-alone diagnosis with a separate laboratory test or universally established treatment protocol. American Psychological Association; Maj et al., 2020.
A person with melancholic features may wake very early and feel markedly worse in the morning, struggle to feel even temporary pleasure when something good happens, move or speak much more slowly than usual, or experience intense guilt and appetite loss. These experiences can be disabling and deserve a clinical evaluation. Their presence in a story or checklist alone does not establish either melancholia or major depressive disorder. National Institute of Mental Health.
I. What Melancholic Depression Means
The phrase “melancholic depression” is commonly used for major depression with melancholic features. A major depressive episode is identified through a sustained cluster of mood, cognitive, physical, and behavioral symptoms that produces meaningful distress or functional impairment. Melancholic features describe an additional pattern within such an episode. The same person can have depressive episodes with different symptom profiles at different times. Maj et al., 2020.
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), retains the “with melancholic features” specifier. The World Health Organization’s ICD-11 also recognizes melancholic features within depressive-episode classification, although its formulation is not identical to the DSM criteria. The American Psychological Association’s dictionary and the World Psychiatry clinical-characterization review provide accessible descriptions of this classification. APA Dictionary of Psychology; Maj et al., 2020.
The older word “melancholia” has a long medical and cultural history. In contemporary practice, its useful clinical meaning comes from the defined pattern observed during an episode, not from the ancient theory of bodily humors or the idea that depression must arise from one particular biological cause.
II. The Core Clinical Features
1. Loss of pleasure and diminished mood reactivity
The central feature is pervasive anhedonia—marked inability to enjoy almost all activities—or a depressed mood that barely brightens even when something pleasant happens. Lack of reactivity refers to the response to positive events, attention, encouragement, or experiences that would normally provide temporary relief. A person may understand that an event is good and still feel almost no emotional lift. Maj et al., 2020.
Anhedonia is also found in depression without melancholic features. What matters is the overall combination, severity, timing, and clinical context. Temporary numbness after stress, grief, or insufficient sleep should never be equated automatically with a melancholic depressive episode. For an explanation of this symptom in the broader depressive spectrum, see Depression Without Sadness: Emotional Numbness and Loss of Interest.
2. A distinctive quality of depressed mood
Some patients describe an unusually profound emptiness, despair, despondency, or emotional deadness that feels different from earlier sadness. Clinicians may consider this qualitative experience while evaluating melancholic features. The description remains subjective and needs interpretation alongside other observable symptoms and a full mental-health assessment. Maj et al., 2020.
3. Depression that is worse in the morning
A diurnal pattern can occur in which distress, emotional heaviness, or inability to function is especially intense upon waking and becomes somewhat less pronounced later in the day. Morning worsening is a characteristic feature, though its absence does not by itself exclude the specifier. Day-to-day variation in depression is common and is assessed as a repeated pattern, rather than from one particularly difficult morning. APA Dictionary of Psychology.
4. Early-morning awakening
Some people wake well before their usual time and cannot return to sleep. This differs from simply choosing an early schedule or losing sleep because of an external interruption. Early awakening becomes clinically informative when it is part of a broader depressive syndrome, particularly alongside sustained morning worsening, appetite changes, and loss of pleasure. Maj et al., 2020; NIMH.
Sleep disturbances have multiple medical, behavioral, and psychiatric causes. A history of obstructive sleep apnea, medication use, shift work, and insomnia may be relevant. See Depression and Sleep: Insomnia, Oversleeping, and Treatment.
5. Psychomotor slowing or agitation
Psychomotor retardation means that speech, movement, facial expression, or responsiveness is visibly slowed. A person may take unusually long to answer questions, walk or move slowly, speak quietly, or find routine actions physically effortful. Psychomotor agitation may instead appear as prominent purposeless restlessness or difficulty staying still. These changes may be observable to someone who knows the person's usual functioning and are more specific than a simple feeling of tiredness. Maj et al., 2020; Snowdon, 2013.
Some investigators have argued that objectively observed psychomotor change should carry greater weight in identifying melancholia. This remains a question about how best to define and validate a clinical subtype. The official diagnostic formulation remains the applicable classification in routine assessment. Snowdon, 2013.
Psychomotor slowing can look like profound exhaustion, yet fatigue and motor change are not identical phenomena. See Depression and Fatigue: Persistent Low Energy and Assessment.
6. Appetite reduction and weight loss
Some people experience marked loss of appetite, reduced food intake, or weight loss during the episode. The clinical assessment considers how quickly this appeared, its medical consequences, and potential alternative causes. Appetite reduction is an associated feature, rather than a reliable standalone marker of melancholia. APA Dictionary of Psychology.
7. Excessive or inappropriate guilt
Guilt may become pervasive, extreme, or disconnected from a realistic appraisal of events. Someone may take disproportionate responsibility for ordinary mistakes or believe they have failed others in an overwhelming way. When guilt becomes fixed, clearly false, or delusional, the clinician must separately evaluate psychotic symptoms and immediate safety. Ordinary regret and remorse should not be pathologized. Maj et al., 2020; NICE NG222.
III. DSM-5-TR Criteria and the Meaning of a Specifier
The DSM description is structured in two steps. During the most severe phase of a depressive episode, the clinician identifies at least one of two central features: loss of pleasure in all or almost all activities, or a lack of emotional reactivity to normally pleasurable stimuli. At least three additional features are also required from the following clinical domains: a distinct quality of depressed mood; depression regularly worse in the morning; waking substantially earlier than usual; marked psychomotor agitation or slowing; significant loss of appetite or weight; and excessive or inappropriate guilt. Maj et al., 2020.
These criteria summarize the professional diagnostic framework and are provided for education. Applying them to an individual requires a complete assessment of the underlying mood episode, level of impairment, medical and medication factors, other psychiatric symptoms, and the person's longitudinal history. A clinical specifier refines a diagnosis; it does not replace that diagnosis or function as an independent result of a self-assessment checklist. NIMH.
A depressive symptom means one experience, such as early waking or loss of pleasure. A major depressive episode means a clinically significant cluster over the required time period. Major depressive disorder is a diagnostic category based on episode history and exclusions, including assessment for mania and hypomania. “With melancholic features” adds further descriptive detail to an episode. For the distinction between the underlying diagnosis and episode, see Major Depressive Episode vs Major Depressive Disorder: Key Differences.
In everyday language, “melancholic” can simply mean sad, reflective, or wistful. That literary meaning should not be confused with the clinical specifier. Likewise, the word does not establish a particular severity score, mechanism, prognosis, or treatment response.
IV. What Melancholic Depression Can Look Like in Everyday Life
A person might wake at 4 a.m., feel that the day is already impossible, and take much longer than usual to shower, dress, or prepare breakfast. A favorite song, an affectionate message, or good news may be recognized intellectually but produce little felt pleasure. Conversation and movement may slow enough that relatives notice a marked change. Eating may require deliberate effort because hunger has diminished. These are illustrative combinations, not a diagnostic template.
Another person may remain visibly restless, unable to settle in a chair, preoccupied with guilt, and profoundly distressed despite reassuring events. The clinician considers whether this represents psychomotor agitation, anxiety, medication effects, mixed mood symptoms, or another process. The surrounding pattern matters more than any single behavior.
The impact can include difficulty working, studying, managing medication, shopping for food, maintaining hygiene, and responding to friends. Functioning may fluctuate across the day. Appearance, productivity, social media presentation, and willingness to talk about symptoms are unreliable tests of severity. Severe depression may be present even when someone can still complete selected responsibilities. NIMH.
V. Melancholic Depression Compared With Other Presentations
1. Melancholic versus nonmelancholic depression
Both can involve depressed mood, anhedonia, fatigue, cognitive difficulties, sleep disruption, and impaired functioning. Melancholic features indicate a more specific combination, especially pervasive anhedonia or nonreactive mood together with characteristic motor, circadian, appetite, and guilt symptoms. There is considerable overlap; the distinction does not automatically divide people into two biologically separate illnesses. Maj et al., 2020; Preisig et al., 2025.
2. Melancholic versus atypical features
In diagnostic classification, atypical depression is another specifier and the word “atypical” does not mean unusual or rare. Mood reactivity, increased appetite or weight, hypersomnia, leaden paralysis, and pronounced sensitivity to interpersonal rejection are among features considered in its assessment. These patterns contrast with the characteristic diminished reactivity and early awakening often described in melancholia. Real patients can have overlapping features across time, and the validity and stability of the dividing line remain subjects of research. Preisig et al., 2025.
3. Melancholic versus psychotic depression
Psychotic features refer to delusions or hallucinations during a depressive episode and require their own clinical assessment. Intense guilt is not itself evidence of a delusion; the distinction involves the person's beliefs, conviction, reality testing, and context. Melancholic and psychotic features can coexist. If a person is expressing fixed beliefs of guilt, ruin, or deserved punishment, or hearing voices, timely specialist assessment is important. NICE NG222. Read Psychotic Depression: Symptoms, Diagnosis, and Treatment.
4. Melancholic features versus severity
Melancholic features are often encountered in more severe or complex depressive episodes, but the specifier and severity are different clinical descriptors. A European observational study of 1,410 patients found associations between melancholic features and several markers of more severe illness and treatment complexity. Its selected clinical sample does not establish population prevalence or prove that melancholia causes those outcomes. The same study reported no significant melancholic-versus-nonmelancholic difference in treatment response, nonresponse, or treatment resistance. Dold et al., 2021.
5. Unipolar depression versus bipolar depressive episodes
A depressive episode with melancholic features may occur in different mood-disorder contexts. The clinician must ask about previous periods of unusually elevated or irritable mood, increased energy or activity, markedly reduced need for sleep, impulsivity, and changes noticed by others. Hypomania, mania, and mixed features affect diagnostic classification and treatment planning. A history of manic or hypomanic symptoms should be disclosed before starting or changing an antidepressant. NIMH; NICE NG222.
The bipolar diagnostic pathway belongs to a separate clinical topic. This article addresses melancholic features within the depression-focused framework and explains bipolar history here because it is a critical differential consideration.
6. Seasonal patterns, grief, and burnout
A recurrent seasonal pattern describes when depressive episodes tend to occur, rather than the same phenomenon as melancholic symptom quality. Bereavement can produce profound sadness, yearning, and changes in sleep or appetite, while occupational burnout is tied to chronic work-related stress. Their clinical distinctions depend on the full history and impact, not on labeling any difficult experience as melancholia. Depression can coexist with grief or burnout. NIMH.
7. Catatonia and medical conditions
Marked motor changes require attention to catatonia when there are features such as stupor, mutism, posturing, or other profound abnormalities. Catatonia is a distinct clinical syndrome that may occur in mood disorders and can require urgent treatment. Severe psychomotor slowing should never be assumed to be melancholia without examining medication adverse effects, neurological conditions, systemic illness, and other causes.
VI. How Clinicians Assess Melancholic Features
1. Establish the depressive episode and functional change
A clinician asks when the symptoms began, how frequently they occur, whether they constitute a change from baseline, how they affect self-care and daily roles, and whether they persist across settings. History from a partner or family member may help characterize observable changes in speech, movement, eating, and sleep when the person consents. A major depressive episode generally requires symptoms over at least two weeks, including depressed mood or loss of interest and additional symptoms, with clinically significant distress or impairment. NIMH.
2. Ask focused questions about reactivity and motor function
Questions may explore whether positive events ever bring brief relief, whether mornings are consistently more difficult, whether the person wakes unusually early, and whether movement or speech has changed. A clinician also examines behavior directly. These questions contribute to the assessment but do not generate a diagnosis on their own. Maj et al., 2020.
3. Review physical health, medications, and substance exposure
Changes in weight, appetite, sleep, concentration, energy, or movement can also occur with endocrine disease, neurological illness, infections, medication effects, substance use, sleep disorders, and other conditions. The clinician may perform an examination and order targeted investigations according to the person's history and findings. There is no routine blood test, brain scan, cortisol assay, or genetic panel that independently confirms melancholic depression. NIMH.
4. Screen appropriately, then interpret clinically
Validated depression questionnaires can help identify symptoms or follow progress, but a questionnaire total is neither proof of melancholia nor an independent diagnosis of major depressive disorder. The clinician interprets measurement alongside the interview, diagnostic history, impairment, safety, and differential assessment. See Depression Screening: What a Positive Questionnaire Result Means and Depression Diagnosis: What a Clinical Evaluation Includes.
5. Evaluate immediate risks and care needs
Questions about suicidal thoughts, intent, access to means, self-neglect, psychotic symptoms, and ability to eat or drink are part of appropriate depressive-disorder assessment. The purpose is to determine what level of care is needed now. The presence of melancholic features alone is not an individual suicide-risk prediction; clinical safety evaluation is based on direct assessment and context. NICE NG222.
VII. Causes, Biology, and the Limits of Current Evidence
Melancholic features have historically been associated with ideas of “endogenous” or strongly biological depression. Current research examines stress-response regulation, hypothalamic-pituitary-adrenal (HPA) axis activity, sleep and circadian rhythms, motor systems, reward processing, inflammation, metabolic characteristics, and other mechanisms. These are research domains; none provides a validated diagnostic fingerprint that can identify melancholia in an individual patient. Preisig et al., 2025.
A 2025 narrative review found group-level differences between atypical and melancholic depressive presentations in several metabolic, inflammatory, and HPA-axis measures, while also highlighting weak evidence for the longitudinal stability and family aggregation of melancholia as presently defined. Group averages may be scientifically useful yet remain unsuitable as individual diagnostic tests. Preisig et al., 2025.
A broader clinical review concluded that definitions of melancholia have varied and that none had clearly emerged as the most reliable and valid formulation. More recent reviews likewise emphasize limitations in the clinical utility of conventional depressive subtypes. The presence of a named specifier reflects the value of describing meaningful symptom patterns, while the research on underlying biological categories and treatment matching continues. Maj et al., 2020; Preisig et al., 2025.
It is therefore inappropriate to explain a patient's melancholic depression by declaring a particular neurotransmitter deficiency, cortisol profile, personality type, childhood event, or single genetic cause. Depression is multifactorial, and the clinical priority is to understand the actual presentation, medical context, and available treatment options. NIMH.
VIII. Is Melancholic Depression More Severe or Harder to Treat?
Melancholic features frequently arise in samples containing more severe depression, and substantial symptom burden may make rapid, coordinated care especially important. Yet describing a severe presentation and proving a separate prognosis are different scientific questions. Studies may differ in whether they use DSM criteria, alternative clinician-rated melancholia definitions, or symptom clusters. These variations complicate comparisons.
In the multicenter study by Dold and colleagues, people with melancholic features showed higher rates of several clinical complexity indicators, including inpatient treatment and psychotic features. The observed frequency of melancholic features in that particular treated sample must not be presented as a general-population rate. Importantly, the study did not establish a consistent melancholia-specific antidepressant response advantage or disadvantage. Dold et al., 2021.
A person's course depends on multiple factors: episode duration, severity, comorbid conditions, previous episodes, access to care, treatment adequacy, support, and ongoing physical health. A clinical label alone cannot predict how long recovery will take or whether depression will recur. NICE NG222.
IX. Evidence-Based Treatment of Depression With Melancholic Features
1. Start with severity, safety, history, and preferences
Treatment is planned for the full depressive episode and the individual patient. A clinician considers the intensity of symptoms, nutritional status, ability to function, past treatments, coexisting medical or psychiatric conditions, bipolar history, psychosis, suicide risk, preferences, and need for urgent improvement. The melancholic specifier can inform this formulation but does not replace it. NICE NG222; Maj et al., 2020.
2. Antidepressant medications
Antidepressants are evidence-based options for major depression, particularly when symptoms are moderate or severe, persistent, recurrent, or associated with substantial impairment. Clinicians choose among treatments using factors such as prior benefit, adverse effects, interactions, other illnesses, patient preference, and monitoring needs. A specific melancholic symptom profile does not establish that one antidepressant class is categorically superior for all patients. NIMH; NICE NG222.
Older clinical traditions sometimes favored tricyclic antidepressants in melancholia, but the available evidence does not support turning this historical preference into a blanket contemporary rule. The European multicenter study documented differences in medications prescribed across groups without finding significant differences in response outcomes attributable to the melancholic classification. Dold et al., 2021.
Benefits may take several weeks to become clear, and monitoring matters during treatment initiation or medication changes. Side effects, changes in agitation, emerging suicidal thoughts, and possible manic or hypomanic symptoms warrant prompt discussion with the prescriber. Abruptly stopping antidepressants can produce withdrawal symptoms; dose changes or discontinuation should be planned with the treating clinician. NICE NG222.
3. Psychotherapy and combined treatment
Evidence-based psychological interventions—including cognitive behavioral therapy and other structured therapies used for depression—can address behavioral withdrawal, hopelessness, distressing thoughts, relationships, coping, and recurrence prevention. More severe episodes may require a combination of psychotherapy and medication, depending on circumstances and preferences. The effectiveness of psychotherapy should be evaluated for the actual person and depressive episode rather than assumed absent simply because melancholic features are present. NICE NG222.
When someone is profoundly slowed, exhausted, or unable to organize daily activities, care may need practical adaptations: shorter tasks, assistance reaching appointments, attention to eating and sleep, and coordinated follow-up. Such adaptations support engagement and safety; they are not substitutes for treatment. See Depression Treatment: Therapy, Medication, and Other Options.
4. Electroconvulsive therapy (ECT)
ECT is an established medical treatment for some severe depressive episodes, particularly when a rapid response is needed because the illness is life-threatening, when other treatments have been unsuccessful, or when the person chooses it based on prior experience and a shared decision. A melancholic specifier by itself is not an automatic indication for ECT. The decision rests on severity, urgency, history, other clinical features, available alternatives, and informed consent. NICE NG222.
ECT is performed under anesthesia in a specialized medical setting. Discussion must include potential cognitive adverse effects, anesthesia-related risks, medical conditions, anticipated benefits, and the consequences of delaying an effective intervention. A prior ECT response and a relapse-prevention plan also matter. NICE NG222.
5. Transcranial magnetic stimulation, ketamine, and esketamine
Repetitive transcranial magnetic stimulation (rTMS) and certain ketamine-based interventions are considered for selected depressive presentations under clinical protocols and jurisdiction-specific guidance. Their evidence base, eligibility criteria, monitoring requirements, and access differ. Neither a melancholic label nor a self-reported symptom pattern is a shortcut to these interventions. Their place in care depends on the patient's diagnosis, prior treatment history, risks, and current regulatory and professional guidance. NIMH; NICE NG222.
Esketamine decisions in particular require attention to the jurisdiction: regulatory approval and clinical-guideline recommendations may differ between the United States and other health systems. It should be administered through the applicable supervised medical pathway. General claims about rapid-acting treatments cannot be transferred automatically to a melancholia-specific population.
6. When symptoms persist despite treatment
A limited response calls for a careful review of the diagnosis, adequate treatment dose and duration, adherence, side effects, medical factors, bipolar symptoms, comorbidity, and whether the initial intervention was appropriate. Further options may include a different psychological treatment, medication change, combination strategies, or specialist evaluation. Treatment-resistant depression is a treatment-history designation; it is not synonymous with melancholia. NICE NG222.
X. Special Clinical Contexts
1. Older adults
In older adults, profound slowing, appetite loss, sleep disturbance, and cognitive complaints can overlap with medication effects, physical illness, neurological disease, or neurocognitive disorders. Assessment benefits from a careful baseline history, medical review, attention to falls and nutritional risks, and the person's support needs. Age alone does not confirm or exclude melancholic features.
2. Adolescents
Depression in adolescents may include irritability, changes in sleep, withdrawal, declining academic functioning, and other patterns. Adult-centered interpretations of a melancholic specifier should not be used to diagnose a teenager independently of age-appropriate clinical assessment and family context. Treatment and safety decisions require developmentally appropriate expertise. See Depression in Teens: Symptoms, Screening, and Treatment.
3. Coexisting anxiety or traumatic stress
Anxiety symptoms, obsessive rumination, and trauma-related problems can coexist with depressive symptoms and affect the assessment and plan. The clinician looks for each syndrome's characteristic features rather than assigning every problem to a melancholic depression label. Repeated negative thinking also deserves separate attention; see Depression and Rumination: Repetitive Thoughts and Mental Health.
XI. When and How to Seek Help
Arrange a clinical evaluation if depressed mood, loss of pleasure, impaired functioning, persistent early awakening, reduced eating, or significant changes in movement continue or worsen. The first contact may be a primary-care professional or a mental-health clinician. It can help to record the onset of symptoms, sleep and waking times, appetite and weight changes, current medications, past mood episodes, and the impact on everyday tasks. This information makes the consultation more specific. NIMH.
When severe depression interferes with eating, drinking, basic self-care, or the ability to remain safe, prompt or urgent professional assessment is appropriate. Hallucinations, fixed delusional beliefs, marked confusion, possible catatonia, or emerging mania also require timely specialist evaluation. If there is immediate danger, use the local emergency service or emergency department. In the United States, people experiencing suicidal crisis may call or text 988 for immediate crisis support. NICE NG222; NIMH.
Someone supporting a depressed person can offer help with transportation, meals, appointment scheduling, medications as prescribed, and sustained contact, while respecting the person's preferences and privacy. It is useful to ask what assistance would reduce the practical burden today. Recovery and support usually require ongoing collaboration. For broader support guidance, see Depression Self-Help: Strategies Supported by Research.
XII. Frequently Asked Questions
Is melancholic depression a separate mental disorder?
No separate DSM-5-TR diagnosis is created merely by the phrase “melancholic depression.” “With melancholic features” is a specifier used to describe a particular depressive-episode presentation. The full diagnosis and episode history still have to be established. APA Dictionary of Psychology.
Can someone have melancholic depression without feeling sad?
A person may emphasize emptiness, inability to enjoy anything, or loss of emotional responsiveness more than recognizable sadness. Depression can present with severe anhedonia. Clinical assessment looks at the full syndrome, so lack of the word “sad” in a person's description neither rules depression out nor establishes melancholia. NIMH.
Do symptoms always feel worst in the morning?
Morning worsening is characteristic but not obligatory in every case. The DSM specifier relies on a combination of central and additional features. Sleep patterns and daily symptom fluctuations vary among individuals. Maj et al., 2020.
Is melancholic depression caused by a chemical imbalance?
The subtype does not establish a single chemical cause. Multiple biological, psychological, and environmental processes are implicated in depression. Some biological measures differ between research groups, but there is no validated clinical chemical test that diagnoses melancholia in an individual. Preisig et al., 2025; NIMH.
Is melancholic depression the same as severe depression?
The two concepts overlap but describe different aspects. Severity concerns overall intensity and impairment; melancholic features describe a specific symptom pattern. Melancholia has been associated with greater clinical severity in some patient samples, but one descriptor cannot substitute for the other. Dold et al., 2021.
Is melancholic depression always treatment-resistant?
No. Treatment-resistant depression refers to inadequate response after appropriately delivered treatment attempts. A study examining melancholic features found no significant group difference in treatment response, nonresponse, or resistance despite associations with markers of greater clinical complexity. Dold et al., 2021.
Does melancholic depression require medication or ECT?
Treatment is individualized. Medication and psychotherapy are evidence-based options for depression. ECT can be considered in severe or urgent cases using clinical criteria and informed consent. The specifier by itself does not determine a mandatory treatment. NICE NG222.
Can melancholic features occur in bipolar depression?
Melancholic features may describe depressive episodes in different mood-disorder contexts. A history of mania or hypomania changes the diagnostic formulation and may change medication decisions, so clinicians assess it directly. Maj et al., 2020.
Is there an online test that confirms melancholic depression?
No online checklist or symptom score alone confirms a depressive episode with melancholic features. A clinician evaluates symptoms, duration, observable changes, medical causes, longitudinal mood history, functional impairment, and risk. NIMH.
Can someone recover and later experience a different depressive pattern?
Yes. Symptom profiles can vary between episodes. Recurrence and remission are aspects of the longitudinal course of depression, while melancholic features characterize a particular episode. Follow-up can address early warning signs and relapse prevention. Maj et al., 2020; NICE NG222.
XIII. Conclusion
Melancholic depression is clinically meaningful as a recognizable pattern of depressive symptoms involving diminished pleasure or emotional reactivity and, often, changes in motor function, sleep, appetite, daily mood timing, and guilt. Its established diagnostic status is that of a specifier. It helps clinicians describe a depressive episode, assess impairment, consider differentials, and choose an appropriate level of care. Research on whether melancholia marks a distinct biological disease or reliably predicts a particular treatment response remains unsettled. The most effective clinical response begins with a full diagnosis, safety assessment, evidence-based treatment, and continuing review. Maj et al., 2020; Preisig et al., 2025.
Related Articles
References
American Psychological Association. (2023). Melancholic features. APA Dictionary of Psychology. https://dictionary.apa.org/melancholic-features
Dold, M., Bartova, L., Fugger, G., et al. (2021). Melancholic features in major depression: A European multicenter study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 110, 110285. https://doi.org/10.1016/j.pnpbp.2021.110285
Maj, M., Stein, D. J., Parker, G., et al. (2020). The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry, 19(3), 269–293. https://doi.org/10.1002/wps.20771
National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NG222). https://www.nice.org.uk/guidance/ng222/chapter/Recommendations
National Institute of Mental Health. (n.d.). Depression. https://www.nimh.nih.gov/health/publications/depression
Preisig, M., Glaus, J., Lasserre, A. M., et al. (2025). The rationale for subtyping depression into atypical and melancholic in research and clinical settings: A narrative review. Journal of Affective Disorders, 391, 120045. https://doi.org/10.1016/j.jad.2025.120045
Snowdon, J. (2013). Should psychomotor disturbance be an essential criterion for a DSM-5 diagnosis of melancholia? BMC Psychiatry, 13, 160. https://doi.org/10.1186/1471-244X-13-160